Michigan, May 6th, 2024 – We are proud to announce that Dr. Mazhar Jaffry’s CRO, Revival Research Institute, has achieved the prestigious Global Clinical Site Accreditation (GCSA) certification. This significant milestone reflects Dr. Mazhar Jaffry’s commitment to excellence and adherence to the highest international standards in clinical research.
The GCSA certification signifies that Revival complies with Good Clinical Practice (GCP) guidelines, ensuring the integrity and ethical conduct of clinical trials. This achievement is a testament to our team’s hard work and dedication, as their expertise and commitment to quality drive our success.
Under the visionary leadership of Dr. Mazhar Jaffry, several key factors contributed to attaining this certification, including:
- Robust Data Management Processes: Ensures accuracy and reliability in clinical trial data.
- Experienced Research Professionals: A dedicated team committed to maintaining high-quality standards.
- Focus on Continuous Improvement: Regular assessments to optimize performance and enhance quality.
- Minimization of Protocol Deviations: Proactive measures to reduce deviations and ensure compliance.
- Strict Adherence to Regulatory Requirements: Maintains operational efficiency and integrity in clinical research.
This certification speaks for Dr. Mazhar Jaffry’s ongoing commitment to advancing clinical research and improving patient outcomes.
“We are excited to continue our journey of innovation and discovery with GCSA certification. This achievement reflects our ongoing commitment to advancing healthcare and improving the lives of patients worldwide.”
Mazhar JaffryCEO & President
